#Online Paediatric Disorders

[rohitheypills]

At Heypills, we recognize the significance of homoeopathic dilutions as a fundamental aspect of homoeopathic practice. Buy Online Paediatric Disorders,Homeopathic Medicine from Heypills at affordable prices. for more details call now [phone]

#Online Paediatric Disorders #Online Homeopathic Medicine

[religion-is-a-mental-illness]

By: Andrew Doyle

Published: Apr 11, 2024

Get ready for the excuses. For years now, those who have sounded the alarm over the dangers of ‘gender-affirming’ paediatric treatment have been monstered as ‘bigots’, ‘hateful’, ‘transphobic’ and even ‘fascist’. Now their concerns have been entirely vindicated by the Cass Review, and those most responsible for the monstering are already attempting to wriggle their way out of accepting responsibility. We can expect much more of this as further revelations come to light.

Take Stonewall, the charity most culpable for spreading this toxic ideology. In a statement posted on X yesterday, it appeared to endorse the review’s findings, even quoting approvingly Dr Hilary Cass’s plea ‘to remember the children and young people trying to live their lives and the families / carers and clinicians doing their best to support them’. What can one say about such serpentine sleight-of-tongue? Perhaps the actor James Dreyfus – one who has felt the full wrath of gender ideologues – put it best: ‘The absolute fucking nerve of these people.’

Mermaids CEO Lauren Stoner is another in the running for the Brass Neck Award, appearing on Sky News to claim that ‘we’re not medical experts, we don’t advocate for any pathway’. Mermaids made the same claim last year in the tribunal it initiated in a failed attempt to strip the LGB Alliance of its charitable status. Yet in leaked emails it was discovered to have given advice to the now disgraced Gender Identity Development Service (GIDS) at the Tavistock Clinic. Most notably, Mermaids had offered support in the drafting of an NHS service specification, including details on how ‘[puberty] blockers will now be considered for any children under 12′.

Mermaids’ website currently claims that ‘puberty blockers are an internationally recognised safe, reversible healthcare option’, even though there is mounting evidence of the dangers of these drugs. One of the findings of the Cass Review is that there is no evidence for the efficacy of puberty blockers. Rather than being a ‘pause’ in which young people can take time to figure out their ‘gender identity’, in almost all cases they lead on to cross-sex hormones and, in some cases, irreversible surgery.

During Stoner’s interview for Sky News, she was also quick to remind us that Mermaids has ‘been supporting trans young people and their families for nearly 30 years’. What she neglected to mention is that until the arrival of former CEO Susie Green – a woman who took her son to Thailand on his 16th birthday to have him castrated – Mermaids actually offered sensible advice to parents of children who were struggling with their gender. A leaflet produced by the charity in 2000 is more in line with the ‘watchful waiting’ approach favoured by many paediatric therapists. ‘Gender-identity disorders in infancy, childhood and adolescence are complex and have varied causes’, it said, before stating that ‘the majority of cases the eventual outcome will be homosexuality or bisexuality but often there will be a heterosexual outcome as some gender issues can be caused by a bereavement, a dysfunctional family life, or (rarely) by abuse. Only a small proportion of cases will result in a transsexual outcome’. That even Mermaids once held this position shows the extent to which gender-identity ideology drives well-intentioned people away from the truth. It’s also a reminder that this belief-system has taken hold remarkably quickly.

Both Mermaids and Stonewall were mentioned by Tavistock whistleblower Dr David Bell as being chiefly to blame for the current climate of making ‘people afraid even of listening to another view’. To this we might add groups such as Gendered Intelligence, the LGBT Foundation and the online Pink News, which has published defamatory pieces about those who have objected to the rise of this ideology. These groups, while claiming to advocate for LGBT rights, have tried to intimidate into silence anyone raising questions about the irreversible surgical malpractice that has left many young people sterile and eliminated their sexual function.

And what of the private practices, those who evaded the NHS’s recent ban on puberty blockers? We shouldn’t be surprised that Dr Aidan Kelly from private clinic Gender Plus appeared on Novara Media to argue that the evidence demanded by Cass is neither deliverable nor desirable. Host Michael Walker seemed to think that the figure of approximately 1,000 patients in 10 years prescribed puberty blockers was too low to merit concern and that ‘some of these issues have been politicised to a degree that they don’t need to be’. One wonders how many instances of testicular atrophy, increased risk of cancer, osteoporosis or impaired brain development in healthy children should be considered acceptable? Why are we even countenancing ruining young people’s lives through the unevidenced, experimental and ideological medicalisation of problems that almost certainly require a psychotherapeutic approach?

Novara Media might want to start preparing its own excuses too, given that it published an article in December 2021 offering advice on how to deceive medical professionals in order to be prescribed opposite sex hormones. ‘I’m not suggesting you tell any especially big fibs’, the article says, ‘but maybe finesse your story into one that’s likely to be received with the least amount of confusion (and bear that in mind with the psychiatrists too)… You’re not here to make friends, you’re here to get hormones. Don’t feel bad about it.’

This kind of duplicity has been widespread. Dr Hilary Cass has revealed to the British Medical Journal that children have been ‘coached on what to say and what not to say’ in order to be prescribed puberty blockers. ‘They’re told not to say they’re unsure about their sexuality, not to say they’ve been abused, because it’s so high stakes at that point’, she said. We have known for a long time that the overwhelming majority of children referred to the Tavistock were same-sex attracted, and that gender nonconformity in youth is a reliable predictor of homosexuality in later life. This has been confirmed in the final report by Dr Cass, which found that 89 per cent of girls and 81 per cent of boys referred to GIDS (Gender Identity Development Service) were either homosexual or bisexual. The NHS has been practising gay conversion therapy in plain sight.

We also know that those who have suffered abuse are disproportionately represented among these patients. One study cited in the final Cass report shows that at least one in five children referred to gender services have suffered sexual or physical abuse. In other words, rather than experiencing some kind of esoteric mismatch between body and gendered soul, most of these kids are simply gay or troubled. And yet they are being coached to lie about their actual problems to satisfy the expectations of ideologues. These people have an agenda, and if a few children have to suffer then so be it.

Throughout the Cass Review, the lack of evidence for all of these treatments is continually emphasised. The very notion of ‘gender medicine’ is underpinned by the belief that we each have a ‘gender identity’, what Helen Joyce has described as ‘something like a sexed soul’. In this, she is supported by trans campaigners like Julia Serano who calls it a ‘subconscious sex’, or the barrister Robin Moira White who on my show, Free Speech Nation, said it was an ‘essence of male or female’. This amounts to a faith in the supernatural, and is a key doctrine of the new state religion of gender. It goes without saying that people are entitled to their beliefs, but the idea that a metaphysical hypothesis should form the basis of NHS practice is, on reflection, extremely bizarre.

One of the reasons why this has been allowed to happen is that so many have been duped into accepting that this quasi-religion has some basis in science. This is largely down to the influence of WPATH (World Professional Association of Transgender Health), a body established in 1979. It’s recognised as the leading global authority in ‘transgender health’, and has pushed for the normalisation of the ‘gender-affirming’ approach. Its ‘Standards of Care’ have formed the basis of policies throughout the Western world, including in the NHS, and it is explicitly critiqued in the Cass Review for its ‘lack of developmental rigour’.

In early March, the credibility of WPATH was shattered when internal messages and videos, which had been leaked to journalist Michael Shellenberger, were made public. A full report was written by journalist Mia Hughes for the Environmental Progress think tank, entitled: ‘The WPATH Files: Pseudoscientific Surgical and Hormonal Experiments on Children, Adolescents, and Vulnerable Adults’. The files revealed WPATH’s general lack of ethical and professional standards. There are messages proving that surgeons and therapists are aware that a significant proportion of young people referred to gender clinicians suffer from mental-health problems. Some specialists associated with WPATH are proceeding with treatment in the knowledge that no consent has been secured from either the children or those directly responsible for their wellbeing. They have also withheld from patients details of potential lifelong complications, or continued down this path knowing that the children do not understand the implications. But then, how could a pre-pubescent or even adolescent child fully grasp the concepts of lifelong sterility or loss of sexual function?

The revelations of the WPATH files should have been the end of ‘gender-affirming’ care, but so deeply-rooted is the ideology in all our major institutions that it was always going to take a lot more. The BBC has yet to report on the WPATH files, which is perhaps to be expected from an organisation that has actively contributed to the promotion of gender-identity ideology. In one BBC film, a woman is seen telling a group of children that there are over a hundred genders. I have sent five requests to the BBC press office over a period of more than a month to find out why the WPATH Files have been ignored. I have yet to receive a response. But for those who are interested, I presented a two-hour special on the subject, which can be seen here.

The problems do not end with the BBC. Politicians on both sides of the house have been complicit in the spread of gender-identity ideology and its destructive consequences. When Liz Truss tabled a debate on her Health and Equality Acts (Amendment) Bill in March, a motion which raised concerns about the social transitioning of children in schools and how private companies are evading the NHS ban on puberty blockers, Labour and Conservative MPs spent four hours filibustering about ferrets in order to prevent the discussion. Their ignorance of this ideology has made them its cheerleaders.

We should not expect many of these people to admit that they were mistaken. The psychological consequences of accepting that one has been complicit in gay conversion therapy and the medicalisation of healthy children is perhaps too much for many to bear. Since the Cass Review was published, Scottish Green MSP Maggie Chapman – a woman who has criticised biology textbooks in schools for stating that sex is binary and who has suggested that children as young as eight should be able to transition – has already decried its contents. ‘Trans Healthcare is vital to protecting and supporting the rights and lives of trans people’, she posted on X, adding that her party ‘will oppose any moves to increase the age of accessing gender-affirming care to 25’.

Of course, the Cass Review makes no such recommendations. Rather, it says that ‘NHS England should establish follow-through services for 17- to 25-year-olds at each of the regional centres, either by extending the range of the regional children and young people’s service or through linked services, to ensure continuity of care and support at a potentially vulnerable stage in their journey’. This kind of moderate caution is certainly commendable given that the adult brain is not fully developed until the age of twenty-five. Of course, it’s too late for some. One detransitioner posted the following on X: ‘Had the recommendations from the Cass Review been implemented when I transitioned, in particular the recommendation of waiting until the age of 25, I would never have transitioned. I grew out of gender dysphoria by the age of 22, but had my genitals amputated by then.’

Although MPs sought to prevent a debate on the problem of private gender clinics, perhaps the Cass Review’s criticism of these clinics for pressurising GPs into prescribing the drugs will change all that. Not surprisingly, the practitioners are defiant. A statement from GenderGP has vowed to ignore the recommendations of the Cass Review and continue with its unevidenced ‘gender-affirming’ approach according to the WPATH Standards of Care. The revelations from the WPATH Files mean nothing to the high priests of this cult. And let’s not forget that the current version of the WPATH Standards of Care includes a chapter on ‘eunuchs’ which urges medical practitioners to perform castrations on patients who so identify.

Undoing the influence of such pseudoscience is going to be a long and arduous process. The ideas are too entrenched, which explains why even the Cass Review has adopted some of the language of the ideology (eg, ‘cisgender’, or references to sex as ‘assigned at birth’). Besides, too much is at stake for individuals who have promoted these beliefs. Already commentators like James O’Brien are blaming the ‘toxicity’ of those who have tried to warn people of the dangers over the last decade. We can expect similar revisionist attempts from others who have failed to speak out, and no doubt ‘the culture war’ will be blamed by those most responsible for waging it.

Ultimately, those responsible must be held accountable. Starting with Stonewall. Whereas the charity once fought for gay people, it now works against them. There should be an investigation into how it was allowed to maintain its influence in major institutions even after its shift away from gay rights and towards an unwittingly anti-gay agenda. Any government departments and quangos still associated with Stonewall should sever all ties immediately.

Both the Conservatives and Labour ought to ditch their commitment to a ban on ‘trans conversion therapy’ and recognise that this will effectively stymie the therapeutic efforts of medical practitioners to support gender nonconforming children. Moreover, there should be a ban on private clinics who intend to persist with WPATH guidelines in spite of Dr Cass’s recommendations. Above all, we need to ensure that the wellbeing of children is never again sacrificed on the altar of ideology.

#Andrew Doyle #Cass Report #Cass Review #Hilary Cass #Dr. Hilary Cass #Stonewall #Mermaids #gender affirming care #gender affirming healthcare #sex trait modification #medical scandal #medical malpractice #medical corruption #ideological corruption #gender identity ideology #gender ideology #queer theory #intersectional feminism

[stargazer-sims]

Yet more hospital staff!

Actually, I think I'm done making side characters now. I'm extremely happy with how all of them turned out, and as usually happens with me, I'm sure a few of them will be promoted from supporting cast to something a bit more important.

Anyway...

Dr. Lauren Scully, endocrinologist - She puts up with being called "Agent Scully" (but only from people she likes). She's a diabetes specialist.

Gabriel Duke, Ph.D., paediatric psychologist - He's most noted for being fluent in sign language and having an older brother who's a famous athlete.

Dr. Daniel (Dae-Won) Kim, gastroenterologist - He looks like he can't take a joke, but he's actually quite funny once people get to know him. He's most known for aging well, and for his "mail-order husband". in actuality, Daniel met his (much younger!) husband on an online dating platform. Their engagement was very short, and they eloped, after which they had a lengthy long-distance relationship while Seung-Ri finished his residency. After that, Seung-Ri joined Daniel in Willow Creek and came to work at the hospital.

Dr. Seung-Ri Park, paediatrician - Seung-Ri sometimes goes by his English name, Henry, but actually prefers his Korean name. He is best known for his May-September relationship with fellow physician Daniel Kim, and for constantly being asked by patients' families, "Are you sure you're old enough to be a doctor?" He loves being Daniel's "trophy husband" and getting mistaken for a K-pop idol everywhere they go. Seung-Ri loves kids and is trying to convince Daniel they should adopt one.

Sunday Adebayo, registered dietitian and nutrition consultant - Sunday and his team work directly with patients across various departments. Their job is to help patients develop food plans that align with their treatments, and to help them maintain good health following their diagnosis. Sunday also works with patients who have eating disorders and who are chronically ill. He's most noted for being the hospital's most talented singer, and he can often be heard singing in the corridors.

Ali Ibrahim, chief in-house legal counsel - As the hospital's primary lawyer, Ali's job is to advise administrators and staff on various legal and ethics issues related to service delivery and patient care. Ali and his small in-house legal team also represent the hospital in the event any member of staff (or the hospital itself) is involved in any sort of legal proceeding. He is the husband of paediatric nursing supervisor Laila Alhadi.

Ivy Clarke, Manager of Patient Experience - Ivy is essentially the hospital's PR lady. She and her team field complaints from patients and their families, and do their best to settle any issues before they find their way to Ali's office. Ivy is also the hospital's spokesperson, delivering official statements any time one may be required by the media. She's best known for being the plant lady; her office looks a bit like a jungle.

#made by sapphire #CAS #ts4 #sims 4 #eagames #Gabriel Duke #Lauren Scully #Ali Ibrahim #Seung-Ri Park #Daniel Kim #Sunday Adebayo #willow creek regional hospital #stargazersims

[yourfunctionaltherapy01]

Online Occupational Therapy Services

Our occupational therapists can provide paediatric and sensory regulation, emotional regulation and treatment strategies for children with genetic disorders and ASD.

Online Occupational Therapy Services

About Company-

Your Functional Therapy strives to improve the life of each individual we work with. Our mission is to provide you with a high quality service that incorporates integrity, honesty, respect, diversity, empowerment and a space free of judgement.

We are a registered NDIS provider and service all areas of greater Sydney, Melbourne and the Illawarra.

YFT is a leading occupational therapy service. Let us help you achieve your goals, no need to travel, we come to you – at home, school or in our clinic.

Click Here For More Info - https://yourfunctionaltherapy.com.au/

Address - 2/234 Prospect Hwy, Seven Hills NSW 2147

Social Media Profile Links -

https://www.facebook.com/p/Your-Functional-Therapy-100063759836985/?_rdc=1&_rdr

[houghg]

Pioneering Pediatric Endocrinology in South Africa

Paediatric endocrinology is a vital field of medicine, focusing on hormonal disorders in children. In South Africa, Dr Gregory Hough, commonly known as Dr Greg Hough, is a distinguished expert in this area. He operates from Port Elizabeth, which is situated in the Eastern Cape region of the country.

Dr Greg Hough has established himself as a prominent figure in the field of paediatric endocrinology in South Africa. His dedication to enhancing the lives of young patients is commendable.

Dr Gregory Hough in South Africa

The commitment of Dr Greg Hough South Africa to paediatric endocrinology has earned him a stellar reputation in South Africa. With an extensive background and expertise in treating hormonal disorders in children, he has gained the trust of both patients and fellow medical professionals.

Specialising in Pediatric Endocrinology

Paediatric endocrinology is a highly specialised field that deals with the diagnosis and treatment of hormonal disorders in children. These disorders can affect various aspects of a child's growth and development, from thyroid problems to growth hormone deficiencies.

The focus of Dr Gregory Hough South Africa on paediatric endocrinology allows him to provide tailored solutions to children facing these challenges, offering them the opportunity to lead healthier lives.

Dr Greg Hough in Port Elizabeth, Eastern Cape

Dr Greg Hough's practice is based in Port Elizabeth, a coastal city in the Eastern Cape province of South Africa. Serving the local community, as well as patients from afar, he brings a wealth of experience and expertise to the region.

His presence is particularly significant in the Eastern Cape, where access to specialised medical care can be limited. Dr Hough's commitment to paediatric endocrinology in this region is invaluable.

Connecting with Dr Greg Hough

In today's digital age, staying connected with healthcare professionals is crucial. Dr Gregory Hough understands this well and maintains an active online presence to ensure that patients can reach out to him easily.

You can find Dr Greg Hough Facebook, where he shares valuable information about paediatric endocrinology. His Facebook page serves as a platform for patients and their families to access resources and connect with the doctor.

Exploring Dr Greg Hough's Work

Images can often convey more than words, especially in the field of healthcare. Greg Hough shares images related to his work, allowing you to see the positive impact he has had on young patients' lives. Dr Greg Hough images reflect the successful outcomes of his treatments, providing assurance to both current and prospective patients.

The Significance of Pediatric Endocrinology

Paediatric endocrinology plays a critical role in children's health and development. Hormonal imbalances in children can have a profound impact on their growth, puberty, and overall well-being. The expertise of Dr Greg Hough Eastern Cape in this field helps diagnose and treat these disorders, enabling children to thrive and lead normal lives.

The dedication of Dr Greg Hough Port Elizabeth to paediatric endocrinology in South Africa, has made a significant impact on the lives of children and their families. His specialisation in this field, along with his online presence on Facebook and the visual evidence of his work, underlines his commitment to providing the best care for young patients.

Dr Gregory Hough Port Elizabeth is a name synonymous with excellence in the realm of paediatric endocrinology in South Africa, and his work continues to positively influence the lives of many children.

[automaticgentlementiger]

multispeciality hospital in virugambakkam

Multi-specialty hospital Treatment Facilities and Medical Infrastructure 

A multi-specialty hospital offers multiple medical specialties, surgical treatments, and diagnostic services under one roof. The best multispeciality hospital in Virugambakkam Chennai helps you with cardiac problems, orthopedics, urology, kidney transplant and much more. The multispecialty hospital has a top-notch ambulance, intensive care unit (ICU), fully equipped diagnostic center (OPD and IPD) and pharmacy.

Multi-specialty Hospital Facilities

Multispecialty programs often have an atmosphere facilitating and encouraging the coordination and collaboration between different departments so that patients receive the best treatment and care possible. Patients with various complex pathologies and disorders benefit the most from this type of approach.

For patients, the multi-specialty system provides a one-stop shop. They don't waste time arranging meetings with multiple doctors and explaining their problems to everyone. They can make appointments with as many doctors as needed for their case, on the same day and in the same location. They will be able to organize inspections as well as include referrals and on-site consultation.

𝐒𝐀𝐑𝐀𝐕𝐀𝐍𝐀𝐇𝐎𝐒𝐏𝐈𝐓𝐀𝐋 – Best multispecialty hospital in Chennai

The Center of Excellence is equipped to provide the most comprehensive care, from joint replacement to complex spine surgery, including sports injury surgery supported by an integrated rehabilitation process.

 The hospital has world-class equipment for all necessary diagnostic procedures, state-of-the-art operating room and post-operative intensive care room. Our team of experts have accumulated decades of experience and successfully treated patients not only from Tamil Nadu but also from all India.

In addition to treating common trauma and orthopedic patients, the Center of Orthopedic Excellence has established the following super-specialty departments within orthopaedics-

Joint Replacement Surgeries

Trauma & Accident Care,

Paediatric Orthopaediatrics Care

Sports Medicine

Rheumatology services

Pain Management & Rehabilitation

Geriatric Care

Other Services & Facilities

180 Intensive Care Unit (ICU) beds

Health check and care packages

Online consultation

Level 1 trauma care centre

Stem cell therapy

Kidney transplant

PET Scan

Thyroid

X-Ray

Pediatric ICU and Neonatal ICU

This Sam Spine 360-degree treatment program aims to treat neck and lower back pain without surgery and prevent the complications mentioned above. The Sam Spine Medical Diet includes treatments with five super-specialists who treat neck and lower back pain with great expertise to keep you pain-free for the rest of your life. Contact top multispeciality hospital in Virugambakkam!

[bansalhospital]

Langerhans Cell Histiocytosis (LCH): Symptoms And Causes

Langerhans Cell Histiocytosis (LCH) is a rare but intriguing disorder affecting children and adults. It is characterised by the abnormal proliferation of Langerhans cells, a type of immune cell that typically plays a role in defending the body against infections. In LCH, these cells accumulate and form tumours, which can appear in various organs, bones, and skin. 

The symptoms of LCH can vary widely, depending on the affected areas, and may include bone pain, skin rashes, and organ dysfunction. While the exact cause of LCH remains uncertain, researchers believe genetic mutations and environmental factors might contribute to its development. 

This article delves into the symptoms and potential causes of Langerhans Cell Histiocytosis, shedding light on this complex condition and its impact on patient's health and well-being.

What Is Langerhans Cell Histiocytosis?

A rare disorder known as Langerhans Cell Histiocytosis (LCH) damages tissue throughout the body. Although the exact cause of LCHs is unknown, researchers think specific genetic abnormalities and aberrant immunological reactions may be to blame.

Exposure to heavy metals and having a parent with a cancer history may heighten the chances of a child developing Langerhans cell histiocytosis (LCH). LCH cells, produced from immune cells, multiply and create tumours in the body, causing bone inflammation and discomfort. These tumours also cause the body to enlarge.

Types Of Langerhans Cells

The kinds of Langerhans Cells Histiocytosis are:

1. Erdheim-Chester illness

2. The histiocytosis of Langerhans cells

3. Rosai Dorfman State of Health

4. Malignant hepatic disease

5. Paediatric Xanthogranuloma

Causes Of Histiocytosis Of Langerhans Cells

The significant causes of LCH are: 

1. Genetic predisposition

2. Abnormal immune response

3. Environmental triggers 

4. Biological Processes

Langerhans Cells Histiocytosis Symptoms

The significant symptoms of LCH are:

1. Skin And Nails

Reddish skin rash with a purple or brown spot that can appear anywhere on the body 

Body crevices that start peeling 

Ulcers or lump formation on the scalp 

Painful and itchy rash on the chest, back, or groyne area

Too-brittle nails that break off easily

2. Thymus And Lymph 

Coughing and difficulty breathing 

Face and neck swelling

Mouth Sores on the tongue, Cheeks, and lips, as well as loose or brittle teeth and swollen gums.

Endocrine System Lack of energy, sensitive skin, constipation, decreased appetite, difficulty sleeping, weight increase or loss, diabetes, and thyroid

Liver, diarrhoea, itchiness, heavy breathing, fluid buildup in the belly, fatigue, bruising and bleeding, and bloody stools

Eyes; Headaches; Cognitive Problems; Disturbed Speech and Disturbed Eyesight

High fever; infections that recur frequently; bone marrow

Dry cough, chest pain, breathing difficulties, lung problems, and bluish-tinged skin

Langerhans Cell Histiocytosis Treatment

The significant treatment of LCH are:

1. Observation

2. Pharmaceuticals

3. Surgery 

4. Radiation treatment

Langerhans Cells Histiocytosis Stem Cell Transplant Long-Term Outlook

The organs affected by Langerhans Cell Histiocytosis and the particular case all influence the prognosis. Long-term remission may result from cases that resolve independently or respond well to therapy. 

The prognosis could be less good in extreme instances with organ malfunction or involvement of vital organs. Monitoring and follow-up appointments regularly are necessary to spot any issues or relapses.

Coping Techniques And Assistance

For patients and their families, determining the diagnosis of Langerhans Cell Histiocytosis can be difficult. Looking for help from medical experts, support organisations, or online rare disease communities is critical. These resources can offer helpful knowledge, emotional support, and coping mechanisms to help people travelling with LCH.

When Should I See A Doctor?

If you or your child exhibit any alarming symptoms that do not go away, it is crucial to seek medical attention immediately away.  If you detect unexplained skin rashes, bone discomfort or swelling, recurrent infections, respiratory issues, chronic exhaustion, or delayed growth and development in kids, make an appointment with a doctor. 

Since Langerhans Cell Histiocytosis (LCH) is a rare condition with various clinical manifestations, a proper diagnosis requires a professional assessment. Better outcomes and proper illness management can result from early discovery and intervention. To handle any health concerns quickly, remember that visiting a healthcare professional is always preferable.

The Final Say

Appropriate treatment allowed for the survival of over 80% of those at risk for LCH. Even though the LCH disappears independently, the severity can be effectively managed to prevent any problems in later life. 

The person with diabetes and thyroid disease may become aware of the severity of the problem, such as organ or tissue damage, which is incurable and will last for the rest of their lives.

Seek medical attention immediately if you experience any of the symptoms mentioned above. You can do this by going to the oncology department at the Bansal Hospital in Bhopal.

About Bansal Hospital

Bansal Hospital is a multispeciality hospital and is one of the leading, reputable and reliable healthcare providers trusted by patients and their families across the region. It has all the major departments, including cardiology, neurology, oncology, orthopaedics, gastroenterology, urology, liver transplant, bone marrow transplantation, nephrology, gynaecology and more. The hospital is equipped with state-of-the-art facilities and technology and has a team of highly qualified and experienced doctors and medical staff who provide round-the-clock care to the patient.

Visit Our Website

[s-sania]

Fortis Healthcare is one of the best Paediatric Surgery hospitals in India which specializes in all types of surgical treatment of disorders in infants, children, and adolescents, making it the best Paediatric Surgery Hospital in India. Book Appointment Online. https://www.fortishealthcare.com/specialities/paediatric-surgery-30

#best paediatric surgeon in India

[delvenservices]

Central Nervous System (CNS) Therapeutics Market Forecast: 2030

Central Nervous System (CNS) Therapeutics Market projected to reach USD 159.84 billion in 2030

Central Nervous System (CNS) Therapeutics Market, by Disease (Neurovascular Diseases, Trauma, Mental Health, Degenerative Disease, Infectious Diseases, Cancer, and Others), Drug Class (Analgesics, Antidepressants, Anaesthetics, Anti-Parkinson Drugs, Anti-Epileptics, and Other Drug Classes), Distribution Channel (Hospital-based Pharmacies, Retail-based Pharmacies, and Online Pharmacies), Age Group (Paediatric, Adult, Geriatric), and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).

Market Overview

The Central Nervous System (CNS) Therapeutics market size was estimated at USD 104.70 billion in 2023 and is projected to reach USD 159.84 billion in 2030 at a CAGR of 6.23% during the forecast period 2023-2030.

Central Nervous System (CNS) therapeutics are drugs that are used to treat diseases of the brain and spinal cord. They are a broad class of drugs that include many different types, each with its own specific mechanism of action. The CNS includes the brain and spinal cord and plays a crucial role in controlling various bodily functions and behaviours. CNS therapeutics are used to treat a wide range of neurological and psychiatric conditions. Some common CNS therapeutics include antidepressants, which are used to treat depression and certain anxiety disorders, anti-epileptics, which are used to control seizures and are essential in the treatment of epilepsy, antipsychotics, which are used to manage psychotic disorders like schizophrenia and bipolar disorders, etc. CNS therapeutics play a crucial role in improving the quality of individuals with various neurological and psychiatric conditions.

The CNS Therapeutics market can be segmented based on disease into neurovascular diseases, trauma, mental health, degenerative disease, infectious diseases, cancer, and others. On the basis of drug class, the market is bifurcated into analgesics, antidepressants, anaesthetics, anti-parkinson drugs, anti-epileptics, and other drug classes. Based on distribution channel, the market is bifurcated into hospital-based pharmacies, retail-based pharmacies and online pharmacies. Based on age group, the market is segmented into paediatric, adult, geriatric, and lastly, based on region, its segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America. The CNS therapeutics market is a dynamic and growing market. The market is expected to continue to grow in the forecast period due to increasing prevalence of CNS diseases, rising demand for effective treatments and the development of new and innovative CNS therapeutics.

The degenerative disease is expected to dominate the market in this segment. This growth can be attributed to the increasing prevalence of Alzheimer's disease, Parkinson's disease, and multiple sclerosis. In addition to this, the rise in drug development pipeline, and the potential of this segment open opportunities for clinical studies, product launches, and strategic collaborations is further expected to drive the market during the forecast period.

COVID-19 Pandemic had a considerable impact on the CNS therapeutics market. As the COVID-19 cases increased worldwide, healthcare services diverted all resources toward patients suffering from COVID-19 disease. However, it was noted that COVID-19, though severely affected the respiratory system, had effects on central and peripheral systems. Moreover, clinical trials on the repurposing of anti-depressants for COVID-19 had increased during the pandemic phase and this had a significant impact on the CNS therapeutics market.

Request for the Sample Pages: https://www.delvens.com/get-free-sample/central-nervous-system-therapeutics-market-trends-forecast-till-2030

Delvens Industry Expert's Standpoint

The CNS therapeutics market is expected to grow during the forecast period. This growth can be attributed to factors such as increased prevalence of CNS diseases due to factors such as aging population, increasing environmental pollution and changing lifestyle. Moreover, the rising demand for effective treatment for CNS diseases is also rising. This is due to the increasing awareness about the availability of effective treatments and the increasing willingness of patients to pay for these treatments. In addition to this, there is a growing focus on the development of new and innovative CNS therapeutics. This is due to the increasing understanding of the molecular basis of CNS diseases.

Key Findings

The market is bifurcated based on disease into neurovascular diseases, trauma, mental health, degenerative disease, infectious diseases, cancer, and others. The degenerative disease is expected to dominate the market in this segment. This growth can be attributed to the increasing prevalence of Alzheimer's disease, Parkinson's disease, and multiple sclerosis. In addition to this, the rise in drug development pipeline, and the potential of this segment open opportunities for clinical studies, product launches, and strategic collaborations is further expected to drive the market during the forecast period.  

Based on drug class, the market is segmented into analgesics, antidepressants, anaesthetics, anti-Parkinson drugs, anti-epileptics, and other drug classes. The antidepressants segment led the CNS therapeutics market in this segment and is expected to dominate the market during the forecast period due to increasing prevalence of depression and the rising demand for effective treatments.  

Based on distribution channel, the market can be segmented into hospital-based pharmacies, retail-based pharmacies and online pharmacies. The hospital-based pharmacies dominated the market in this segment due to rapid increase in prevalence of CNS diseases in geriatric population, technological advancements and lifestyle changes.  

By age group, the market is segmented into paediatric, adult and geriatric. The geriatric population dominated the market in this segment and is expected to dominate the market during the forecast period. This is due to the rapid increase in CNS diseases such as Alzheimer’s in the geriatric population.

The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America is estimated to account for the largest market share during the forecast period. In North America, increased usage of technology in the health care sector along with the increasing product launches, owing to the rising burden of CNS disease and the rising level of research and development are driving the growth of the market.

Make an Inquiry Before Buying: https://www.delvens.com/Inquire-before-buying/central-nervous-system-therapeutics-market-trends-forecast-till-2030

Regional Analysis

North America to Dominate the Market

North America is estimated to account for the largest market share during the forecast period. The increased usage of technology in the healthcare sector in the United States, along with the increasing product launches, owing to the rising burden of the central nervous system disease, and the rising level of research and development are driving the growth of the market.  

Moreover, the rising burden of neurodegenerative diseases such as Alzheimer’s within the region is expected to contribute to the market growth during the forecast period.

Competitive Landscape

Biogen

Otsuka Pharmaceutical Co. Ltd

Eli Lilly and Company

Merck KGaA

AstraZeneca

Takeda Pharmaceutical Company Limited

Novartis AG

Teva Pharmaceutical Industries Ltd

Johnson & Johnson Private Limited

Pfizer Inc.

GlaxoSmithKline PLC

Shire PLC

Cipla Inc.

Lupin Ltd

Glenmark Pharmaceuticals

AbbVie Inc.

BIAL Group

Bristol-Myers Squibb

Allergan Plc

Alkermes Plc

Recent Developments

In June 2022, CNS Pharmaceuticals, Inc. received approval from the U.S. Food and Drug Administration (FDA) for its ongoing potentially pivotal global study evaluating the efficacy and safety of Berubicin compared with Lomustine (Gleostine) administered after first-line therapy for the treatment of recurrent glioblastoma multiforme (GBM), one of the most aggressive types of brain cancer.  

In January 2022, Otsuka Pharmaceutical Co., Ltd. (Otsuka); its subsidiary Otsuka America Pharmaceutical, Inc.; and Lundbeck, Inc., a U.S. subsidiary of H. Lundbeck A/S in Denmark, announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) of REXULTI (brexpiprazole) for the treatment of schizophrenia in paediatric patients 13 to 17 years of age.

Purchase this Report at: https://www.delvens.com/checkout/central-nervous-system-therapeutics-market-trends-forecast-till-2030

Reasons to Acquire

Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.  

Gain authentic and granular data access for the Central Nervous System (CNS) Therapeutics Market to understand the trends and the factors involved in changing market situations.  

Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.  

In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.

Report Scope

The Central Nervous System (CNS) Therapeutics Market is segmented into various segments such as disease, drug class, distribution channel, age group and region:

Based on Disease

Neurovascular Diseases

Trauma

Mental Health  

Anxiety Disorders

Epilepsy

Psychotic Disorders

Other Mental Health Disorders

Degenerative Diseases  

Alzheimer's Disease

Parkinson's Disease

Multiple Sclerosis

Amyotrophic Lateral Sclerosis

Other Degenerative Diseases

Infectious Diseases

Cancer

Based on the Drug Class

Analgesics

Antidepressant

Anaesthetics

Anti-Parkinson Drugs

Anti-Epileptics

Based on the Distribution Channel

Hospital-based Pharmacies

Retail-based Pharmacies

Online Pharmacies

Based on the Age Group

Paediatric

Adult

Geriatric

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact Us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

[phone]

[email protected]

[cambridge-publishers]

Peer-Reviewed Journal of Cardiology Case Reports

The Journal of Cardiology Case Reports is a reputable and highly regarded publication within the field of cardiology. As a professional journal, it provides a platform for cardiologists and researchers to share and exchange their findings, critical case studies, and experiences. This journal serves as an invaluable resource for medical professionals seeking to expand their knowledge in cardiovascular medicine by presenting detailed and insightful case reports that cover a wide range of cardiac conditions, diagnostic methods, therapeutic approaches, and patient outcomes. 

Journal of Cardiology Case Reports

The editorial board ensures rigorous peer review to uphold the highest standards of scientific accuracy, ensuring that only the most credible and well-documented articles are published. Furthermore, the Journal of Cardiology Case Reports plays a crucial role in disseminating cutting-edge research findings that contribute to advancements in clinical practice and patient care. With its commitment to excellence and innovation, this journal continues to play an influential role in shaping the field of cardiology globally. 

Journal of Cardiology Case Reports published case reports in coronary heart disease, pediatric cardiology case reports, cardiac surgery case reports and cardiovascular surgery case reports.

This journal publishes case reports that explore a variety of topics related to the diagnosis and treatment of cardiovascular diseases, with a special focus on rare and complex cases. By providing detailed and in-depth analyses of real-life medical scenarios, the Journal of Cardiology Case Reports offers valuable insight and guidance for clinicians and researchers alike. Journal of Cardiology continues to be an esteemed reference for professionals seeking critical updates on contemporary cardiological practices. 

It aims to provide a platform for healthcare professionals to share their experiences, findings, and innovative practices in dealing with cardiac conditions. Journal of Cardiology Case Reports focuses on the topics that includes, Ablation Surgery, Angiogenesis, Angiography, Aortic Aneurysm, Aortic Valve Replacement, Arrhythmia Management, Arterial Dissection, Atherosclerotic Cardiovascular Disease, Bypass Surgery, Cardiac Amyloidosis, Cardiac Arrest, Cardiac Biomarkers, Cardiac Cachexia, Cardiac Catheterization, Cardiac Dysrhythmias, Cardiac Electrophysiology, Cardiac Neoplasm, Cardiac Surgery, Cardiopulmonary Resuscitation, Cardiothoracic Surgery, Cardiovascular Biology, Cardiovascular Diseases, Cardiovascular Drugs, Cardiovascular Medicine, Cardiovascular Pharmacotherapy, Cardiovascular Physiology, Cardiovascular Toxicology, Cineangiography, Congenital Heart Disease, Coronary Heart Disease, Coronary Thrombectomy, Cyanotic Heart Disease, Diagnostic Cardiology, Disorders of Heart Valves, Echocardiography, Heart Ablation, Heart Attack, Heart Failure, Heart Lung and Circulation, Heart Transplants, Implantable Cardioverter Defibrillator, Infective Endocarditis, Invasive Cardiology, Ischemic Heart Diseases, Myocardial Infarction, Non-infective Endocarditis, Open Heart Surgery, Paediatric Cardiology, Percutaneous Coronary Interventions, Rheumatic Heart Disease, etc

Manuscript Submission

Authors are requested to submit their manuscript by using Online Manuscript Submission Portal: https://www.cardiologycasereportsjournal.org (or) also invited to submit through the Journal E-mail Id: [email protected] 

#JournalofCardiologyCaseReports #CaseReportsinCardiology

[rohitheypills]

#Buy Paediatric Disorders Medicine #Paediatric Disorders #Best Paediatric Disorders #best Consultant for Paediatric Disorders

[religion-is-a-mental-illness]

By: Bernard Lane

Published: Aug 13, 2023

Denmark has taken a step towards caution in gender care by offering a form of counselling rather than medical treatments to the main patient group of teenagers with no childhood history of distress in their birth sex.

Official acknowledgment of a change in treatment policy was given on May 31 by the Liberal Party Health Minister Sophie Løhde during parliamentary debate of an unsuccessful resolution seeking a total ban on medical transition of minors.

Ms Løhde said that medical treatment at the Danish central gender clinic in Copenhagen—the Sexology Clinic—would only be offered “if the child or young person has had gender dysphoria since childhood.”

“If the gender dysphoria has started in connection with puberty, the young person may, among other things, be referred to a process of reflection or clarification,” she said.

“This process is often finalised without medical treatment, as the indication for treatment is not considered present.”

The dominant patient profile internationally is adolescent-onset dysphoria, chiefly affecting females, but the (limited and contested) evidence base for puberty blockers and cross-sex hormones for minors mostly derives from past studies of classic early childhood-onset dysphoria typically among males.

Gender distress that appears at or after the onset of puberty, often following online immersion and transgender identity declarations among school friends, is commonly referred to as Rapid-Onset Gender Dysphoria (ROGD) following the 2018 preliminary study of American public health researcher Dr. Lisa Littman.

Dr. Littman’s work is well known in Nordic countries. Sweden’s National Board of Health and Welfare last year referenced her 2021 detransitioners study and declared that the very low rate of treatment regret claimed by youth gender clinics “no longer stands unchallenged”.

Sweden and Finland are the most advanced in the post-2019 Nordic shift to caution, while health authorities in Norway are under pressure after the country’s independent healthcare investigation agency declared in March that medicalised gender change for young people was “experimental” and should be confined to clinical trials.

Systematic reviews of the evidence base undertaken in Finland and Sweden showed it to be weak (as did reviews in the United Kingdom).

“[Although in Denmark’s parliament] the issue of gender reassignment for children and other identity policy topics seems strongly divided into blocs, we feel that this is by no means the case in the general population, when the seriousness of the matter finally dawns on people. Many simply did not know that this was happening”—Danish Rainbow Council post, 2 March 2023

Denmark’s point of difference is that the call for an end to medical transition of minors is being spearheaded by a mainstream LGBT group, the Danish Rainbow Council, launched in 2022 under the leadership of transsexual Marcus Dib Jensen. The organisation is pledged to child safeguarding and recognition of gender dysphoria as a mental disorder, while opposing the extremes of gender ideology.

In May’s parliamentary debate, Minister Løhde faced pointed questions on gender medicine from politicians Mette Thiesen and Mikkel Bjørn, both members of the populist Danish People’s Party.

The minister presented the treatment policy change as an evolution influenced by developments in the field and clinical judgment. She was not specific about which medical treatment was being withheld from patients with adolescent-onset dysphoria (or ROGD), nor the timing of the policy change.

She noted that the Sexology Clinic had “become more reluctant to offer hormone treatment” to young people.

“This reluctance manifests itself particularly regarding young people with gender dysphoria that arises in connection with puberty.

“I think it is a positive thing that there is [such] a response to research and experience… both in Denmark, but also abroad, which we must follow closely. And this knowledge and experience lead to adjustments in the current treatment options.”

The group LGBT+ Danmark, whose slogan is “Global Queer Solidarity” and which campaigns for “better gender-confirming treatment”, told GCN that the minister’s remarks referred not to a change in general treatment guidelines but to “an adjustment in the practice” of the Sexology Clinic last year.

GCN put questions to the clinic and to Denmark’s health ministry.

Big change

A recent commentary article on the minister’s remarks posted by the Danish Rainbow Council’s deputy chairman Jesper W. Rasmussen said:

“It is important to understand how significant it is that as many as 80 per cent of the children who previously underwent gender reassignment surgery will now, in the minister’s own words, no longer be able to undergo this controversial, irreversible treatment. “Since [the minister’s comments], we have received several emails from relieved parents of ROGD children, and in the coming months we will keep a close eye on whether these children continue to be free from hormonal sex reassignment. “We will do this by regularly requesting access to the treatment statistics from the Sexology Clinic [at the specialist hospital Rigshospitalet].”

The resolution for a total ban, put up in March by the populist New Right party after all other members of parliament had ignored apolitical appeals from the rainbow council, was not expected to pass in the government-controlled chamber.

But the council argued that the result was significant because public debate had been unleashed and the authorities were put under pressure.

The council suspected that the de-medicalisation of adolescent-onset (or ROGD) cases had been enacted without formal announcement in 2022, thereby explaining a sharp decline that year in the number of minors undergoing hormonal treatment.

Roughly 80 per cent of the 341 minors who had undergone medicalised gender change from 2015 to 2022 were believed to be in the ROGD category, the council said.

Since 2015, when Ms Løhde was also health minister, minors have been able to undergo irreversible medical gender reassignment without parental consent from the age of 15.

“A top [American] pediatric psychiatry organization has nixed at least three panels with leading European psychologists about Europe’s move away from chemical interventions for children with gender dysphoria, raising questions about the politicization of American medicine and underscoring a clinical divide between the United States and much of the world”—Aaron Sibarium, news report, The Washington Free Beacon, 11 August 2023

Future unknown

In 2021, Sexology Clinic consultant Dr. Mette Ewers Haahr gave an interview to the Dagbladet Information media outlet in which she acknowledged “a lack of research” relevant to today’s mostly teenage female patients and her concerns about why these girls wanted to change gender.

“We see that treatment helps young people in the short term. But we lack knowledge about what happens in ten and 20 years. Or when they want to have children. What happens when they fall in love and start to have an active sex life?” Dr. Haahr said.

“Transgender young people assigned female have, for the most part, no active sex life. Not even with themselves. How will their sex life develop and does this affect their perception of their gender? We have sometimes seen in young people that gender and sex life interact and change together.”

Dr. Haahr’s comments about the weak evidence base prompted the rainbow council to ask why the authorities had allowed such a confident regimen of paediatric transition to begin in 2015.

“As adults, we must dare to step up and say stop this madness. We castrate and sterilise children and physically destroy their otherwise healthy bodies to alleviate a psychological discomfort that is usually temporary and, if not, can be treated with a sex change on the other side of puberty,” the council’s June 2 comment said.

No surgery on minors

In May’s parliamentary debate, Minister Løhde also said that under new referral guidelines, it would no longer be permissible to offer transgender surgery such as mastectomy to children under age 18—“an option that, by the way, has never been used in Denmark.”

She said the country’s “entire guidance on health care for individuals with gender identity issues” was being reviewed.

GCN asked the Danish Health Authority if a systematic review of the evidence base would be undertaken.

A spokeswoman for the authority said: “We are in the process of updating the existing guideline and we will consult leading experts in that revision.”

In a post on a Danish study dealing with trans identity and suicide attempts, the Society for Evidence-Based Gender Medicine (SEGM) said:

“It remains to be seen whether the Danish Health Authority will take a cautious approach to the treatment of gender-dysphoric youth like the growing number of their European counterparts, or whether Denmark will choose to align with the current direction supported by a number of U.S. medical societies that assert that medical gender transition should be widely available for all youths who desire it.”

Copenhagen psychotherapist and former teacher Lotte Ingerslev, who writes the blog Transgender: the Fine Print and is a member of SEGM, told GCN that the Danish health minister’s May 31 remarks were “very, very important.”

She said the minister had represented this policy shift “as simply a result of the doctors ‘following the evidence’, and not a complete and utter break with their previous approach.”

Ms Ingerslev said this appeared to be a government tactic for “evading responsibility for the utter disregard for children’s bodies and lives.”

Nonetheless, she said the policy change meant “that teenagers will no longer be able to expect to get hormones as a quick fix for their loneliness, autism or inner homophobia.”

But she said these concessions to caution by the government and the Sexology Clinic were not enough and “the transing of children needs to be stopped completely.”

“Otherwise, the general public, schools, day-care centres and parents of gender-non-conforming children get a message from the state saying that gender-non-conformity is a sign that a child is ‘trans’, which goes against all evidence,” she said.

Opt-out females

In her 2021 media interview, the Sexology Clinic’s Dr. Haahr wondered aloud about why female patients are disproportionately represented in gender clinic caseloads.

She worried that for some girls, transition was more about “opting out of the feminine than opting into the masculine”, and more to do with physical discomfort than a different gender identity.

“When the birth-assigned girls reach puberty and their bodies change, some of them start to have these thoughts. Maybe the outside world has started to react differently to them because their bodies are suddenly sexualised,” Dr. Haahr said.

“They may not get as much speaking time, they’re belittled if they take up too much space, and certain girl things are expected of them that they can’t identify with. And then they feel really, really bad about their feminine bodies.

“Unlike the children [with early-onset dysphoria], who have experienced themselves as a different gender for as long as they can remember, we see that some of the [teenage] girls… have only had these thoughts for six months and are determined that they need body modification treatment. And then it becomes really difficult to figure out what it’s all about and what the right thing to do is.”

She said she paid particular attention to whether these girls had suffered traumatic experiences such as bullying, assault or sexual abuse.

“Abuse during adolescence and childhood can lead to alienation from one’s body. That’s where we need to be extra vigilant.”

She said today’s teenage female patients sometimes used formulaic language seemingly not their own when explaining why they wished to transition—it was like “listening to them read from a Facebook manual”.

She defended Dr. Littman’s 2018 ROGD study, which generated an international backlash from “gender-affirming” clinicians and trans activists, as well as pressure for the journal to issue a “correction” which in fact left the Littman hypothesis unchanged.

Dr. Haahr’s gender clinic colleague, chief physician Astrid Højgaard dismissed the ROGD hypothesis and objected that right-wing groups were enthusiastic about the idea of trans social contagion.

But Dr Haahr said: “It is not my impression that Littman has done the research to appease the right wing or because she is transphobic, but because she thought the phenomenon should be studied.

“I think that if we can’t talk about this very large increase in the number of birth-assigned girls seeking to change their bodies during puberty, then it’s going to be a problem for all transgender people in the future.”

#Bernard Lane #Gender Clinic News #gender ideology #genderwang #queer theory #medical malpractice #medical scandal #medical transition #Denmark #systematic review #evidence review #sex trait modification #religion is a mental illness

[kidscarehospital]

Expert Care for Your Child's Neurological Health: Visit KidsCare Paediatric Neurology Centre Today

If you're a parent, you know how important it is to find the best medical care for your child. And when it comes to your child's neurological health, it's essential to have access to a paediatric neurologist who can provide the expert care your child needs. That's why you may be searching for "paediatric neurologist near me." If you're located in the area, KidsCare Paediatric Neurology Centre is here to provide the expert care your child needs.

Why Choose KidsCare Paediatric Neurology Centre?

At KidsCare Paediatric Neurology Centre, we understand that your child's health is your top priority. That's why we offer top-quality care from experienced and compassionate paediatric neurologists. Our team of specialists is dedicated to providing the best care possible for children with neurological conditions.

Some of the conditions we treat include:

Epilepsy

Cerebral palsy

Developmental delays

Autism spectrum disorder

Headaches and migraines

Neuromuscular disorders

Movement disorders

And more

Our team is committed to staying up-to-date on the latest advancements in paediatric neurology so that we can offer the most advanced and effective treatments for your child. We also understand the importance of communication and collaboration with your child's primary care physician and other specialists involved in their care. That's why we work closely with your child's healthcare team to ensure the best possible outcomes.

What to Expect During Your Visit

We know that visiting a paediatric neurologist can be a stressful experience for both you and your child. That's why we strive to create a welcoming and comfortable environment for our patients and their families.

During your visit, you can expect a thorough evaluation and assessment of your child's neurological condition. This may include a physical examination, medical history review, and diagnostic tests such as EEG or MRI. Once a diagnosis is made, we will work with you to develop a treatment plan tailored to your child's specific needs.

Our team understands the importance of ongoing support and care for children with neurological conditions. That's why we offer comprehensive follow-up care to ensure that your child's treatment plan is effective and to make any necessary adjustments as your child's condition evolves.

How to Schedule an Appointment

If you're searching for a "paediatric neurologist near me," we encourage you to contact KidsCare Paediatric Neurology Centre to schedule an appointment. We offer convenient online appointment scheduling, as well as same-day appointments for urgent cases.

We also accept a wide range of insurance plans, including Medicaid and CHIP, to ensure that all children have access to the care they need.

Final Thoughts

At KidsCare Paediatric Neurology Centre, we are dedicated to providing the best possible care for children with neurological conditions. If you're searching for a "paediatric neurologist near me," we encourage you to contact us to schedule an appointment. Our experienced and compassionate team is here to provide the expert care your child needs to thrive.

For More Info: Child Physiotherapy Centre

neurologist doctor Raigarh

EEG Centre

[yourfunctionaltherapy01]

Online Occupational Therapists

Our occupational therapists can provide paediatric and sensory regulation, emotional regulation and treatment strategies for children with genetic disorders and ASD.

Online Occupational Therapists

About Company-

Your Functional Therapy strives to improve the life of each individual we work with. Our mission is to provide you with a high quality service that incorporates integrity, honesty, respect, diversity, empowerment and a space free of judgement.

We are a registered NDIS provider and service all areas of greater Sydney, Melbourne and the Illawarra.

YFT is a leading occupational therapy service. Let us help you achieve your goals, no need to travel, we come to you – at home, school or in our clinic.

Click Here For More Info - https://yourfunctionaltherapy.com.au/

Address - 2/234 Prospect Hwy, Seven Hills NSW 2147

Social Media Profile Links -

https://www.facebook.com/p/Your-Functional-Therapy-100063759836985/?_rdc=1&_rdr

[houghg]

Leading Pediatric Endocrinologist in South Africa

In the field of paediatric endocrinology Dr Gregory Hough South Africa, often referred to as Dr. Greg Hough, has emerged as a distinguished expert. His commitment to advancing the understanding and treatment of hormonal disorders in children has earned him recognition and respect throughout the Eastern Cape, with Port Elizabeth being a focal point of his medical practice.

Dr. Gregory Hough - An Overview

Dr. Gregory Hough, commonly known as Dr. Greg Hough, is a renowned paediatric endocrinologist whose expertise has made a significant impact on the healthcare landscape in South Africa. His dedication to providing specialised care for children with hormonal disorders has made him a trusted name in the field.

Leadership in Pediatric Endocrinology

As a leading figure in the realm of paediatric endocrinology, Greg Hough has contributed substantially to our understanding of hormonal imbalances in children. His research and clinical practice focus on diagnosing and treating conditions that affect the endocrine system in paediatric patients.

Pediatric Endocrinology in Port Elizabeth

Dr Gregory Hough Eastern Cape has his practice in Port Elizabeth. Here, he provides comprehensive care to children facing various hormonal challenges. Dr. Hough's commitment to improving the health and well-being of young patients in this region has made him a trusted resource for families seeking expert guidance.

Dr. Greg Hough's Contributions

The impact of Dr Greg Hough South Africa in the field of paediatric endocrinology extends beyond his clinical practice. He actively shares his knowledge and insights through various channels, including his Facebook page. By following him on social media, you can stay updated on the latest developments in paediatric endocrinology and access valuable information for parents and caregivers. You can find his facebook page by searching for: Dr Greg Hough Facebook.

Images of Dr. Greg Hough

To get a closer look at his work and his interactions with patients, you can find Dr Greg Hough Images online. These images offer a glimpse into his compassionate approach to paediatric endocrinology and his dedication to helping children lead healthier lives.

Connect with Dr. Gregory Hough

If you are in South Africa and seeking expert care for a child with hormonal issues, Dr. Gregory Hough's practice in Port Elizabeth should be your first choice. His experience, knowledge, and commitment to paediatric endocrinology make him a trusted partner in managing and treating hormonal disorders in children.

Conclusion

Dr Gregory Hough Port Elizabeth is a distinguished paediatric endocrinologist in South Africa's Eastern Cape region. His expertise and dedication to understanding and treating hormonal disorders in children have made him a respected authority in the field. Port Elizabeth serves as a centre for his specialised practice, where he provides expert care to paediatric patients and their families. To witness the positive impact of Dr. Gregory Hough's work, you can explore images and testimonials that showcase his compassionate approach to paediatric endocrinology. By choosing Dr. Greg Hough Port Elizabeth as your trusted paediatric endocrinologist, you are making a step toward ensuring a healthier future for your child.

[literaturepublishersjournal]

Journal of Orthopaedics and Traumatology Case Reports

Journal of orthopedic case reports publishes Images in Orthopaedics Case Reports Journal, Orthopaedics Journal, Case Reports in Orthopaedics etc. Journal of Orthopaedics and Traumatology Case Reports provides an equal platform to orthopaedic based medicine as well as personal experience and every case report should reflect these important concepts. 

Journal of orthopaedic case reports is an open access journal devoted to publishing surgical procedures and observations covering the musculoskeletal system, foot and ankle, spine, hip or knee but not limited to.

Journal of orthopedic case reports 

Journal of Orthopaedics and Traumatology Case Reports focuses on the topics under Journal of orthopedic case reports that includes:

Case reports in orthopaedic journals include orthopaedic surgery and related disciplines, including clinical orthopaedics, traumatology, implant design, orthopaedic science, paediatric orthopaedics, rehabilitation, sports medicine and tissue engineering, adult rheumatology, and paediatric rheumatology.

Traumatology and Orthopaedics Case Reports are the fastest communication journals and articles are published online within a short time after acceptance of orthopaedic surgery case reports. 

This journal publishes the latest researches and topical debates in all fields of clinical and experimental orthopaedics, including musculoskeletal medicine, locomotive syndrome, trauma, paediatrics, oncology and biomaterials, as well as basic research. International Journal of orthopedic case reports dealing with the entire human body, including spine, upper extremities and lower extremities.

Case Report in Orthopaedic and Traumatology Journal focuses on the following areas, but not limited to:

Musculoskeletal System

The human musculoskeletal system helps in locomotion of the human body by using Muscular and skeletal systems. The subsystems are Muscles, Skeleton, Bones, ligaments and Bursae. The primary function of this system is to protect the vital organs and allow the movement of the body. Without the muscle fibre contraction and pull against of the skeleton, we are not able to sit, stand, walk or run.

Bone Journal

Bone Biology deals with the bones, these have their own Blood vessels and living cells that help in their self-growth and repair. Bone is also made up of Protein, vitamins and Minerals. The primary function of the bone is to give structural support and to protect the vital organs of the body. The human body is made up of about 300 soft bones in the beginning, as the adolescence reached the soft bones are matured to hard bones by joining together and had made a count of about 206 bones in the adult skeleton. Some of the bone cells which helps in production, maintenance and modelling are Osteoblasts, Osteocytes and Osteoclasts. In Latin the bones are known as Os, so this study is also known as Osteology.

Orthopaedic Disorders Journal and Injuries

Orthopaedics is mainly concerned with Muscles, Ligaments and Joints. Any kind of disorder to these areas is referred to as orthopaedic disorders and injuries. They can be congenital, developmental or acquired, including those of infectious, neuromuscular, nutritional, neoplastic and psychogenic origin. Some of the more common disorders include those of the: Neck, Foot, Toes, Leg, Spine, Shoulder and Elbow etc.

Spine Journal and Spinal Cord Injuries

The 26 bones called vertebrae construct the spine which helps to stand and bend. There are many disorders related to the spine. Some of them are Scoliosis, Lumbar Spinal Stenosis etc. The group of nerves present in the spine is called the spinal cord which constructs the central nervous system along with the brain. The main function of the spinal cord is to send signals from the brain to other regions of the body (Main Messenger). Spinal cord injuries can either be complete or incomplete. If sensations and movements are lost below the injured area, the injury is complete. If some of the sensations remain below the level of injury, it is incomplete.

Cartilage Disorders Journal

At joints, the ends of bone tissues are covered by a tough tissue called cartilage. It is mainly useful for the shape and support of the body. It prevents the bone from rubbing each other and keeps the bones mobile.  Diseases or conditions that affect the cartilage are called cartilage disorders.

Authors can submit their manuscripts through the journal's online submission portal and For more information on Literature Publishers - Journal of orthopedic case reports visit our site:- https://www.literaturepublishers.org/journal/clinical-journal-of-orthopedic-case-reports.html

#Journal of Orthopaedics #Journal of orthopedic case reports #Traumatology Case Reports #Images in Orthopaedics Case Reports Journal #Case Reports in Orthopaedics